Fast Five Quiz: Heart Failure With Reduced Ejection Fraction (HFrEF) Treatment Optimization

Alanna Morris, MD; Michael Weber, MD; Jeffrey J. Hsu, MD

November 16, 2023

A washout period when switching from an ACEI to an ARNI is required to reduce the risk for angioedema; ACEI and ARNI combination therapy is contraindicated owing to this risk. Other contraindications that have been linked to ARNI include medication allergy, hyperkalemia, hypotension, and pregnancy; combination therapy with aliskiren is not recommended.

An ARNI may also be used in combination with an SGLT2 inhibitor; however, as these medications both have diuretic effects, dosages of concomitantly prescribed diuretics may need to be adjusted.

Learn more about the role of ARNIs in the treatment of HFrEF.

1 2 3 4 5 6

Next Section

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Alanna Morris, Michael Weber, Jeffrey J. Hsu. Fast Five Quiz: Heart Failure With Reduced Ejection Fraction (HFrEF) Treatment Optimization - Medscape - Nov 16, 2023.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.